Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Life-threatening complications of vitamin D intoxication due to over-the-counter supplements.
Kaptein S, Risselada AJ, Boerma EC, Egbers PH, Nieboer P. Kaptein S, et al. Among authors: nieboer p. Clin Toxicol (Phila). 2010 Jun;48(5):460-2. doi: 10.3109/15563650.2010.486382. Clin Toxicol (Phila). 2010. PMID: 20515399
Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study.
Nieboer P, Buijs C, Rodenhuis S, Seynaeve C, Beex LV, van der Wall E, Richel DJ, Nooij MA, Voest EE, Hupperets P, Mulder NH, van der Graaf WT, TenVergert EM, van Tinteren H, de Vries EG. Nieboer P, et al. J Clin Oncol. 2005 Nov 20;23(33):8296-304. doi: 10.1200/JCO.2005.10.167. Epub 2005 Oct 11. J Clin Oncol. 2005. PMID: 16219926 Clinical Trial.

Linear mixed effect models showed that the higher the Hb level (P = .0006) and mental health score (P < .0001), the less fatigue was experienced. Joint (P < .0001) and muscle pain (P = .0283) were associated with more fatigue. CONCLUSION: In 3 ye

Linear mixed effect models showed that the higher the Hb level (P = .0006) and mental health score (P < .0001), the less fa

Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study.
Buijs C, Mom CH, Willemse PH, Marike Boezen H, Maurer JM, Wymenga AN, de Jong RS, Nieboer P, de Vries EG, Mourits MJ. Buijs C, et al. Among authors: nieboer p. Breast Cancer Res Treat. 2009 Jun;115(3):573-80. doi: 10.1007/s10549-008-0138-7. Epub 2008 Aug 1. Breast Cancer Res Treat. 2009. PMID: 18670875 Clinical Trial.
Premature discontinuation for toxicity occurred in 14/59 during venlafaxine and 5/53 during clonidine (P = .038). Venlafaxine induced more side effects. ...
Premature discontinuation for toxicity occurred in 14/59 during venlafaxine and 5/53 during clonidine (P = .038). Venlafaxine induced …
Vertebral fracture assessment in supine position: comparison by using conventional semiquantitative radiography and visual radiography.
Hospers IC, van der Laan JG, Zeebregts CJ, Nieboer P, Wolffenbuttel BH, Dierckx RA, Kreeftenberg HG, Jager PL, Slart RH. Hospers IC, et al. Among authors: nieboer p. Radiology. 2009 Jun;251(3):822-8. doi: 10.1148/radiol.2513080887. Epub 2009 Apr 20. Radiology. 2009. PMID: 19380691
Delirium after interleukin-2 and alpha-interferon therapy for renal cell carcinoma.
van Steijn JH, Nieboer P, Hospers GA, de Vries EG, Mulder NH. van Steijn JH, et al. Among authors: nieboer p. Anticancer Res. 2001 Sep-Oct;21(5):3699-700. Anticancer Res. 2001. PMID: 11848546
Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients.
Nieboer P, de Vries EG, Mulder NH, Rodenhuis S, Bontenbal M, van der Wall E, van Hoesel QG, Smit WM, Hupperets P, Voest EE, Nooij MA, Boezen HM, van der Graaf WT. Nieboer P, et al. Bone Marrow Transplant. 2008 Oct;42(7):475-81. doi: 10.1038/bmt.2008.195. Epub 2008 Jul 14. Bone Marrow Transplant. 2008. PMID: 18622420 Clinical Trial.
Cox regression analysis showed that duration of neutropenia >10 days (P=0.04), using the catheter for both stem-cell apheresis and high-dose chemotherapy (P= <0.01), and use of total parenteral nutrition (TPN, P=0.04) were predictive for catheter-relate …
Cox regression analysis showed that duration of neutropenia >10 days (P=0.04), using the catheter for both stem-cell apheresis and …
Catecholamine dependency in a polytrauma patient: relative adrenal insufficiency?
Nieboer P, van der Werf TS, Beentjes JA, Tulleken JE, Zijlstra JG, Ligtenberg JJ. Nieboer P, et al. Intensive Care Med. 2000 Jan;26(1):125-7. doi: 10.1007/s001340050024. Intensive Care Med. 2000. PMID: 10663293
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.
Henricks LM, Lunenburg CATC, de Man FM, Meulendijks D, Frederix GWJ, Kienhuis E, Creemers GJ, Baars A, Dezentjé VO, Imholz ALT, Jeurissen FJF, Portielje JEA, Jansen RLH, Hamberg P, Ten Tije AJ, Droogendijk HJ, Koopman M, Nieboer P, van de Poel MHW, Mandigers CMPW, Rosing H, Beijnen JH, Werkhoven EV, van Kuilenburg ABP, van Schaik RHN, Mathijssen RHJ, Swen JJ, Gelderblom H, Cats A, Guchelaar HJ, Schellens JHM. Henricks LM, et al. Among authors: nieboer p. Lancet Oncol. 2018 Nov;19(11):1459-1467. doi: 10.1016/S1470-2045(18)30686-7. Epub 2018 Oct 19. Lancet Oncol. 2018. PMID: 30348537 Clinical Trial.
Angiotensin II-Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer: A Randomized Clinical Trial.
Boekhout AH, Gietema JA, Milojkovic Kerklaan B, van Werkhoven ED, Altena R, Honkoop A, Los M, Smit WM, Nieboer P, Smorenburg CH, Mandigers CM, van der Wouw AJ, Kessels L, van der Velden AW, Ottevanger PB, Smilde T, de Boer J, van Veldhuisen DJ, Kema IP, de Vries EG, Schellens JH. Boekhout AH, et al. Among authors: nieboer p. JAMA Oncol. 2016 Aug 1;2(8):1030-7. doi: 10.1001/jamaoncol.2016.1726. JAMA Oncol. 2016. PMID: 27348762 Clinical Trial.
There were 3.8% more cardiac events in the candesartan group than in the placebo group (95% CI, -7% to 15%; P = .58): 20 events (19%) and 16 events (16%), respectively. The 2-year cumulative incidence of cardiac events was 0.28 (95% CI, 0.13-0.40) in the candesartan group …
There were 3.8% more cardiac events in the candesartan group than in the placebo group (95% CI, -7% to 15%; P = .58): 20 events (19%) …
Relevance of high-dose chemotherapy in solid tumours.
Nieboer P, de Vries EG, Mulder NH, van der Graaf WT. Nieboer P, et al. Cancer Treat Rev. 2005 May;31(3):210-25. doi: 10.1016/j.ctrv.2005.02.002. Epub 2005 Mar 19. Cancer Treat Rev. 2005. PMID: 15944050 Review.
44 results
Jump to page
Feedback